lobbying_filings_raw: c9eb9138-d99b-4ab2-8296-e856b32a2ff8
This data as json
| filing_uuid | filing_type | registrant_id | registrant_name | client_id | client_name | filing_year | filing_period | received_date | amount_reported | is_amendment | is_no_activity | is_termination | raw_json | registrant_state | registrant_country | registrant_house_id | client_state | client_ppb_state | client_country | client_ppb_country | client_general_description | client_government_entity | affiliated_org_count | client_entity_id | client_government_unit_id | client_match_method | client_match_confidence |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| c9eb9138-d99b-4ab2-8296-e856b32a2ff8 | Q4 | 1923 | AMERICAN CLINICAL LABORATORY ASSN | 102665 | AMERICAN CLINICAL LABORATORY ASSN | 2019 | fourth_quarter | 2020-01-17T12:27:03.727000-05:00 | 324826.0 | 0 | 0 | 0 | {"url": "https://lda.senate.gov/api/v1/filings/c9eb9138-d99b-4ab2-8296-e856b32a2ff8/", "filing_uuid": "c9eb9138-d99b-4ab2-8296-e856b32a2ff8", "filing_type": "Q4", "filing_type_display": "4th Quarter - Report", "filing_year": 2019, "filing_period": "fourth_quarter", "filing_period_display": "4th Quarter (Oct 1 - Dec 31)", "filing_document_url": "https://lda.senate.gov/filings/public/filing/c9eb9138-d99b-4ab2-8296-e856b32a2ff8/print/", "filing_document_content_type": "text/html", "income": null, "expenses": "324826.00", "expenses_method": "c", "expenses_method_display": "Method C - Reporting amounts under section 162(e) of the Internal Revenue Code", "posted_by_name": "Thomas Bryant Sparkman", "dt_posted": "2020-01-17T12:27:03.727000-05:00", "termination_date": null, "registrant_country": "United States of America", "registrant_ppb_country": null, "registrant_address_1": "1100 New York Avenue, Suite 725 West", "registrant_address_2": null, "registrant_different_address": false, "registrant_city": "WASHINGTON", "registrant_state": "DC", "registrant_zip": "20005", "registrant": {"id": 1923, "url": "https://lda.senate.gov/api/v1/registrants/1923/", "house_registrant_id": 30533, "name": "AMERICAN CLINICAL LABORATORY ASSN", "description": "national trade association for clinical laboratories", "address_1": "1201 Pennsylvania Ave, NW", "address_2": "Suite 810", "address_3": null, "address_4": null, "city": "WASHINGTON", "state": "DC", "state_display": "District of Columbia", "zip": "20004", "country": "US", "country_display": "United States of America", "ppb_country": "US", "ppb_country_display": "United States of America", "contact_name": "HOLLY BRUGGEN", "contact_telephone": "+1 202-637-9466", "dt_updated": "2026-01-20T16:03:44.906224-05:00"}, "client": {"id": 102665, "url": "https://lda.senate.gov/api/v1/clients/102665/", "client_id": 12, "name": "AMERICAN CLINICAL LABORATORY ASSN", "general_description": null, "client_government_entity": false, "client_self_select": true, "state": "DC", "state_display": "District of Columbia", "country": "US", "country_display": "United States of America", "ppb_state": "DC", "ppb_state_display": "District of Columbia", "ppb_country": "US", "ppb_country_display": "United States of America", "effective_date": "2012-12-07"}, "lobbying_activities": [{"general_issue_code": "HCR", "general_issue_code_display": "Health Issues", "description": "regulation and oversight of clinical laboratories, including laboratory developed test services and pharmacogenetic testing, the Diagnostic Accuracy and Innovation Act discussion draft and Verifying Accurate, Leading-edge IVCT Development Act discussion draft; reimbursement and coverage issues for and related to clinical laboratory services, including the Medicare clinical laboratory fee schedule, physician fee schedule, new test coding and pricing, TRICARE coverage and reimbursement, and implementation of the Protecting Access to Medicare Act (P.L. 113-93); narrowing the in-office ancillary services exception to the federal self-referral statute to remove anatomic pathology, advanced diagnostic imaging, physical therapy, and radiation therapy; Medicare physician signature documentation requirements; National Diabetes Prevention Program; commercial laboratory surge capacity issues for response to pandemic/epidemic/public health crises, Anti-Kickback Law relating to clinical laboratories, surprise billing issues relating to clinical laboratory and ancillary providers. Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, FY2020; Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2020; Medicare reimbursement of clinical laboratory services; SUPPORT for Patients and Communities Act (PL 115-271), H.R. 3584/S. 3049 Laboratory Access for Beneficiaries Act, H.R. 3630 No Surprises Act, S. 1895 Lower Health Care Costs Act, S. 1531 Stopping The Outrageous Practice of Surprise Medical Bills Act of 2019, S. 1266 Protecting Patients from Surprise Medical Bills Act, H.R. 3502 Protecting People from Surprise Medical Bills Act, H.R. 861 End Surprise Billing Act of 2019, H.R. 2328 Reauthorizing and Extending Americas Community Health Act, H.R. 3107 Improving Seniors' Timely Access to Care Act of 2019, H.R. 2143 Promoting Integrity in Medicare Act of 2019, H.R. 269 Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019, S. 1379 Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019, H.R. 3055 Commerce, Justice, Science, Agriculture, Rural Development, Food and Drug Administration, Interior, Environment, Military Construction, Veterans Affairs, Transportation, and Housing and Urban Development Appropriations Act, 2020, H.R. 2740 Labor, Health and Human Services, Education, Defense, State, Foreign Operations, and Energy and Water Development Appropriations Act, 2020, H.R. 4378 Continuing Appropriations Act, 2020, and Health Extenders Act, H.R. 3055 Further Continuing Appropriations Act, 2020, and Further Health Extenders Act of 2019, H.R. 1158 Consolidated Appropriations Act, 2020, H.R. 1865 Further Consolidated Appropriations Act, 2020.", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 58320, "prefix": "mr", "prefix_display": "MR.", "first_name": "THOMAS", "nickname": null, "middle_name": "B", "last_name": "SPARKMAN", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 71384, "prefix": null, "prefix_display": null, "first_name": "ELIZABETH", "nickname": null, "middle_name": "A", "last_name": "THOMAS", "suffix": null, "suffix_display": null}, "covered_position": "Legislative Director, Office of Congressman Andy Barr (KY-06); Senior Legislative Assistant, Office of Congressman Andy Barr (KY-06); Legislative Assistant, Office of Congressman Andy Barr (KY-06)", "new": true}], "government_entities": [{"id": 134, "name": "Centers For Disease Control & Prevention (CDC)"}, {"id": 136, "name": "Centers For Medicare and Medicaid Services (CMS)"}, {"id": 25, "name": "Defense, Dept of (DOD)"}, {"id": 135, "name": "Food & Drug Administration (FDA)"}, {"id": 5, "name": "Government Accountability Office (GAO)"}, {"id": 34, "name": "Health & Human Services, Dept of (HHS)"}, {"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 37, "name": "Justice, Dept of (DOJ)"}, {"id": 18, "name": "Office of Management & Budget (OMB)"}, {"id": 1, "name": "SENATE"}, {"id": 12, "name": "White House Office"}]}, {"general_issue_code": "ALC", "general_issue_code_display": "Alcohol and Drug Abuse", "description": "SUPPORT for Patients and Communities Act (PL 115-271), Anti-Kickback Law relating to clinical laboratories", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 58320, "prefix": "mr", "prefix_display": "MR.", "first_name": "THOMAS", "nickname": null, "middle_name": "B", "last_name": "SPARKMAN", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 71384, "prefix": null, "prefix_display": null, "first_name": "ELIZABETH", "nickname": null, "middle_name": "A", "last_name": "THOMAS", "suffix": null, "suffix_display": null}, "covered_position": "Legislative Director, Office of Congressman Andy Barr (KY-06); Senior Legislative Assistant, Office of Congressman Andy Barr (KY-06); Legislative Assistant, Office of Congressman Andy Barr (KY-06)", "new": true}], "government_entities": [{"id": 134, "name": "Centers For Disease Control & Prevention (CDC)"}, {"id": 136, "name": "Centers For Medicare and Medicaid Services (CMS)"}, {"id": 25, "name": "Defense, Dept of (DOD)"}, {"id": 135, "name": "Food & Drug Administration (FDA)"}, {"id": 5, "name": "Government Accountability Office (GAO)"}, {"id": 34, "name": "Health & Human Services, Dept of (HHS)"}, {"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 37, "name": "Justice, Dept of (DOJ)"}, {"id": 18, "name": "Office of Management & Budget (OMB)"}, {"id": 1, "name": "SENATE"}, {"id": 12, "name": "White House Office"}]}, {"general_issue_code": "DIS", "general_issue_code_display": "Disaster Planning/Emergencies", "description": "commercial laboratory surge capacity issues for response to pandemic/epidemic/public health crises; H.R. 269 Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019, S. 1379 Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019.", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 58320, "prefix": "mr", "prefix_display": "MR.", "first_name": "THOMAS", "nickname": null, "middle_name": "B", "last_name": "SPARKMAN", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 71384, "prefix": null, "prefix_display": null, "first_name": "ELIZABETH", "nickname": null, "middle_name": "A", "last_name": "THOMAS", "suffix": null, "suffix_display": null}, "covered_position": "Legislative Director, Office of Congressman Andy Barr (KY-06); Senior Legislative Assistant, Office of Congressman Andy Barr (KY-06); Legislative Assistant, Office of Congressman Andy Barr (KY-06)", "new": true}], "government_entities": [{"id": 134, "name": "Centers For Disease Control & Prevention (CDC)"}, {"id": 136, "name": "Centers For Medicare and Medicaid Services (CMS)"}, {"id": 25, "name": "Defense, Dept of (DOD)"}, {"id": 135, "name": "Food & Drug Administration (FDA)"}, {"id": 5, "name": "Government Accountability Office (GAO)"}, {"id": 34, "name": "Health & Human Services, Dept of (HHS)"}, {"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 37, "name": "Justice, Dept of (DOJ)"}, {"id": 18, "name": "Office of Management & Budget (OMB)"}, {"id": 1, "name": "SENATE"}, {"id": 12, "name": "White House Office"}]}, {"general_issue_code": "MMM", "general_issue_code_display": "Medicare/Medicaid", "description": "reimbursement and coverage issues for and related to clinical laboratory services, including the Medicare clinical laboratory fee schedule, physician fee schedule, new test coding and pricing, and implementation of the Protecting Access to Medicare Act (P.L. 113-93); narrowing the in-office ancillary services exception to the federal self-referral statute to remove anatomic pathology, advanced diagnostic imaging, physical therapy, and radiation therapy; Medicare physician signature documentation requirements; Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2020; Medicare reimbursement of clinical laboratory services; H.R. 3584/S. 3049 Laboratory Access for Beneficiaries Act, H.R. 3630 No Surprises Act, S. 1895 Lower Health Care Costs Act, H.R. 2328 Reauthorizing and Extending Americas Community Health Act, H.R. 3107 Improving Seniors' Timely Access to Care Act of 2019, H.R. 2143 Promoting Integrity in Medicare Act of 2019, H.R. 3055 Commerce, Justice, Science, Agriculture, Rural Development, Food and Drug Administration, Interior, Environment, Military Construction, Veterans Affairs, Transportation, and Housing and Urban Development Appropriations Act, 2020, H.R. 2740 Labor, Health and Human Services, Education, Defense, State, Foreign Operations, and Energy and Water Development Appropriations Act, 2020, H.R. 4378 Continuing Appropriations Act, 2020, and Health Extenders Act, H.R. 3055 Further Continuing Appropriations Act, 2020, and Further Health Extenders Act of 2019, H.R. 1158 Consolidated Appropriations Act, 2020, H.R. 1865 Further Consolidated Appropriations Act, 2020.", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 58320, "prefix": "mr", "prefix_display": "MR.", "first_name": "THOMAS", "nickname": null, "middle_name": "B", "last_name": "SPARKMAN", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 71384, "prefix": null, "prefix_display": null, "first_name": "ELIZABETH", "nickname": null, "middle_name": "A", "last_name": "THOMAS", "suffix": null, "suffix_display": null}, "covered_position": "Legislative Director, Office of Congressman Andy Barr (KY-06); Senior Legislative Assistant, Office of Congressman Andy Barr (KY-06); Legislative Assistant, Office of Congressman Andy Barr (KY-06)", "new": true}], "government_entities": [{"id": 134, "name": "Centers For Disease Control & Prevention (CDC)"}, {"id": 136, "name": "Centers For Medicare and Medicaid Services (CMS)"}, {"id": 25, "name": "Defense, Dept of (DOD)"}, {"id": 135, "name": "Food & Drug Administration (FDA)"}, {"id": 5, "name": "Government Accountability Office (GAO)"}, {"id": 34, "name": "Health & Human Services, Dept of (HHS)"}, {"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 37, "name": "Justice, Dept of (DOJ)"}, {"id": 18, "name": "Office of Management & Budget (OMB)"}, {"id": 1, "name": "SENATE"}, {"id": 12, "name": "White House Office"}]}, {"general_issue_code": "BUD", "general_issue_code_display": "Budget/Appropriations", "description": "regulation and oversight of clinical laboratories, including laboratory developed test services and pharmacogenetic testing, the Diagnostic Accuracy and Innovation Act discussion draft and Verifying Accurate, Leading-edge IVCT Development Act discussion draft; reimbursement and coverage issues for and related to clinical laboratory services, including the Medicare clinical laboratory fee schedule, physician fee schedule, new test coding and pricing, TRICARE coverage and reimbursement, and implementation of the Protecting Access to Medicare Act (P.L. 113-93); narrowing the in-office ancillary services exception to the federal self-referral statute to remove anatomic pathology, advanced diagnostic imaging, physical therapy, and radiation therapy; Medicare physician signature documentation requirements; National Diabetes Prevention Program; commercial laboratory surge capacity issues for response to pandemic/epidemic/public health crises, Anti-Kickback Law relating to clinical laboratories, surprise billing issues relating to clinical laboratory and ancillary providers. Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, FY2020; Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2020; Medicare reimbursement of clinical laboratory services; SUPPORT for Patients and Communities Act (PL 115-271), H.R. 3584/S. 3049 Laboratory Access for Beneficiaries Act, H.R. 3630 No Surprises Act, S. 1895 Lower Health Care Costs Act, S. 1531 Stopping The Outrageous Practice of Surprise Medical Bills Act of 2019, S. 1266 Protecting Patients from Surprise Medical Bills Act, H.R. 3502 Protecting People from Surprise Medical Bills Act, H.R. 861 End Surprise Billing Act of 2019, H.R. 2328 Reauthorizing and Extending Americas Community Health Act, H.R. 3107 Improving Seniors' Timely Access to Care Act of 2019, H.R. 2143 Promoting Integrity in Medicare Act of 2019, H.R. 269 Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019, S. 1379 Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019, H.R. 3055 Commerce, Justice, Science, Agriculture, Rural Development, Food and Drug Administration, Interior, Environment, Military Construction, Veterans Affairs, Transportation, and Housing and Urban Development Appropriations Act, 2020, H.R. 2740 Labor, Health and Human Services, Education, Defense, State, Foreign Operations, and Energy and Water Development Appropriations Act, 2020, H.R. 4378 Continuing Appropriations Act, 2020, and Health Extenders Act, H.R. 3055 Further Continuing Appropriations Act, 2020, and Further Health Extenders Act of 2019, H.R. 1158 Consolidated Appropriations Act, 2020, H.R. 1865 Further Consolidated Appropriations Act, 2020.", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 58320, "prefix": "mr", "prefix_display": "MR.", "first_name": "THOMAS", "nickname": null, "middle_name": "B", "last_name": "SPARKMAN", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 71384, "prefix": null, "prefix_display": null, "first_name": "ELIZABETH", "nickname": null, "middle_name": "A", "last_name": "THOMAS", "suffix": null, "suffix_display": null}, "covered_position": "Legislative Director, Office of Congressman Andy Barr (KY-06); Senior Legislative Assistant, Office of Congressman Andy Barr (KY-06); Legislative Assistant, Office of Congressman Andy Barr (KY-06)", "new": true}], "government_entities": [{"id": 134, "name": "Centers For Disease Control & Prevention (CDC)"}, {"id": 136, "name": "Centers For Medicare and Medicaid Services (CMS)"}, {"id": 25, "name": "Defense, Dept of (DOD)"}, {"id": 135, "name": "Food & Drug Administration (FDA)"}, {"id": 5, "name": "Government Accountability Office (GAO)"}, {"id": 34, "name": "Health & Human Services, Dept of (HHS)"}, {"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 37, "name": "Justice, Dept of (DOJ)"}, {"id": 18, "name": "Office of Management & Budget (OMB)"}, {"id": 1, "name": "SENATE"}, {"id": 12, "name": "White House Office"}]}, {"general_issue_code": "INS", "general_issue_code_display": "Insurance", "description": "surprise billing issues relating to clinical laboratory and ancillary providers, H.R. 3630 No Surprises Act, S. 1895 Lower Health Care Costs Act, S. 1531 Stopping The Outrageous Practice of Surprise Medical Bills Act of 2019, S. 1266 Protecting Patients from Surprise Medical Bills Act, H.R. 3502 Protecting People from Surprise Medical Bills Act, H.R. 861 End Surprise Billing Act of 2019, H.R. 2328 Reauthorizing and Extending Americas Community Health Act, H.R. 3107 Improving Seniors' Timely Access to Care Act of 2019.", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 58320, "prefix": "mr", "prefix_display": "MR.", "first_name": "THOMAS", "nickname": null, "middle_name": "B", "last_name": "SPARKMAN", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 71384, "prefix": null, "prefix_display": null, "first_name": "ELIZABETH", "nickname": null, "middle_name": "A", "last_name": "THOMAS", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 134, "name": "Centers For Disease Control & Prevention (CDC)"}, {"id": 136, "name": "Centers For Medicare and Medicaid Services (CMS)"}, {"id": 25, "name": "Defense, Dept of (DOD)"}, {"id": 135, "name": "Food & Drug Administration (FDA)"}, {"id": 5, "name": "Government Accountability Office (GAO)"}, {"id": 34, "name": "Health & Human Services, Dept of (HHS)"}, {"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 37, "name": "Justice, Dept of (DOJ)"}, {"id": 18, "name": "Office of Management & Budget (OMB)"}, {"id": 1, "name": "SENATE"}, {"id": 12, "name": "White House Office"}]}, {"general_issue_code": "MED", "general_issue_code_display": "Medical/Disease Research/Clinical Labs", "description": "regulation and oversight of clinical laboratories, including laboratory developed test services and pharmacogenetic testing, the Diagnostic Accuracy and Innovation Act discussion draft and Verifying Accurate, Leading-edge IVCT Development Act discussion draft; reimbursement and coverage issues for and related to clinical laboratory services, including the Medicare clinical laboratory fee schedule, physician fee schedule, new test coding and pricing, TRICARE coverage and reimbursement, and implementation of the Protecting Access to Medicare Act (P.L. 113-93); narrowing the in-office ancillary services exception to the federal self-referral statute to remove anatomic pathology, advanced diagnostic imaging, physical therapy, and radiation therapy; Medicare physician signature documentation requirements; National Diabetes Prevention Program; commercial laboratory surge capacity issues for response to pandemic/epidemic/public health crises, Anti-Kickback Law relating to clinical laboratories, surprise billing issues relating to clinical laboratory and ancillary providers. Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, FY2020; Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2020; Medicare reimbursement of clinical laboratory services; SUPPORT for Patients and Communities Act (PL 115-271), H.R. 3584/S. 3049 Laboratory Access for Beneficiaries Act, H.R. 3630 No Surprises Act, S. 1895 Lower Health Care Costs Act, S. 1531 Stopping The Outrageous Practice of Surprise Medical Bills Act of 2019, S. 1266 Protecting Patients from Surprise Medical Bills Act, H.R. 3502 Protecting People from Surprise Medical Bills Act, H.R. 861 End Surprise Billing Act of 2019, H.R. 2328 Reauthorizing and Extending Americas Community Health Act, H.R. 3107 Improving Seniors' Timely Access to Care Act of 2019, H.R. 2143 Promoting Integrity in Medicare Act of 2019, H.R. 269 Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019, S. 1379 Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019, H.R. 3055 Commerce, Justice, Science, Agriculture, Rural Development, Food and Drug Administration, Interior, Environment, Military Construction, Veterans Affairs, Transportation, and Housing and Urban Development Appropriations Act, 2020, H.R. 2740 Labor, Health and Human Services, Education, Defense, State, Foreign Operations, and Energy and Water Development Appropriations Act, 2020, H.R. 4378 Continuing Appropriations Act, 2020, and Health Extenders Act, H.R. 3055 Further Continuing Appropriations Act, 2020, and Further Health Extenders Act of 2019, H.R. 1158 Consolidated Appropriations Act, 2020, H.R. 1865 Further Consolidated Appropriations Act, 2020.", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 58320, "prefix": "mr", "prefix_display": "MR.", "first_name": "THOMAS", "nickname": null, "middle_name": "B", "last_name": "SPARKMAN", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 71384, "prefix": null, "prefix_display": null, "first_name": "ELIZABETH", "nickname": null, "middle_name": "A", "last_name": "THOMAS", "suffix": null, "suffix_display": null}, "covered_position": "Legislative Director, Office of Congressman Andy Barr (KY-06); Senior Legislative Assistant, Office of Congressman Andy Barr (KY-06); Legislative Assistant, Office of Congressman Andy Barr (KY-06)", "new": true}], "government_entities": [{"id": 134, "name": "Centers For Disease Control & Prevention (CDC)"}, {"id": 136, "name": "Centers For Medicare and Medicaid Services (CMS)"}, {"id": 25, "name": "Defense, Dept of (DOD)"}, {"id": 135, "name": "Food & Drug Administration (FDA)"}, {"id": 5, "name": "Government Accountability Office (GAO)"}, {"id": 34, "name": "Health & Human Services, Dept of (HHS)"}, {"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 37, "name": "Justice, Dept of (DOJ)"}, {"id": 18, "name": "Office of Management & Budget (OMB)"}, {"id": 1, "name": "SENATE"}, {"id": 12, "name": "White House Office"}]}, {"general_issue_code": "LAW", "general_issue_code_display": "Law Enforcement/Crime/Criminal Justice", "description": "SUPPORT for Patients and Communities Act (PL 115-271), Anti-Kickback Law relating to clinical laboratories", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 58320, "prefix": "mr", "prefix_display": "MR.", "first_name": "THOMAS", "nickname": null, "middle_name": "B", "last_name": "SPARKMAN", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 71384, "prefix": null, "prefix_display": null, "first_name": "ELIZABETH", "nickname": null, "middle_name": "A", "last_name": "THOMAS", "suffix": null, "suffix_display": null}, "covered_position": "Legislative Director, Office of Congressman Andy Barr (KY-06); Senior Legislative Assistant, Office of Congressman Andy Barr (KY-06); Legislative Assistant, Office of Congressman Andy Barr (KY-06)", "new": true}], "government_entities": [{"id": 134, "name": "Centers For Disease Control & Prevention (CDC)"}, {"id": 136, "name": "Centers For Medicare and Medicaid Services (CMS)"}, {"id": 25, "name": "Defense, Dept of (DOD)"}, {"id": 135, "name": "Food & Drug Administration (FDA)"}, {"id": 5, "name": "Government Accountability Office (GAO)"}, {"id": 34, "name": "Health & Human Services, Dept of (HHS)"}, {"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 37, "name": "Justice, Dept of (DOJ)"}, {"id": 18, "name": "Office of Management & Budget (OMB)"}, {"id": 1, "name": "SENATE"}, {"id": 12, "name": "White House Office"}]}], "conviction_disclosures": [], "foreign_entities": [], "affiliated_organizations": []} | DC | US | 30533 | DC | DC | US | US | 0 | 0 | 259030 | normalized_name_state | 0.9 |